News for Amarillo Biosciences, Inc. (AMAR)

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

Revenues increased by 384% year over year Debt ratio decreased to 7% from 75% at year-end 2021 SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- Ainos, Inc. , a diversified medtech company focused on the... | November 7, 2022

Read Amarillo Biosciences (OTCMKTS:AMAR) Shares Cross Below 50 Day Moving Average of $0.63 at ETF Daily News

aimd_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | October 4, 2022

Read Contrasting Generation Bio (NASDAQ:GBIO) and Ainos (OTCMKTS:AIMD) at ETF Daily News

Read Analyzing Eton Pharmaceuticals (NASDAQ:ETON) and Ainos (OTCMKTS:AIMD) at ETF Daily News

Drug and medtech developer Ainos (AIMD) has updated its financial disclosures for a proposed public offering and uplisting to Nasdaq

Read Amarillo Biosciences (OTCMKTS:AMAR) Share Price Passes Below 50 Day Moving Average of $0.36 at ETF Daily News

Read Ainos (OTCMKTS:AIMD) versus Alaunos Therapeutics (NASDAQ:TCRT) Critical Review at ETF Daily News